Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $94.19 USD
Change Today +0.45 / 0.48%
Volume 1.1M
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

dexcom inc (DXCM) Key Developments

DexCom, Inc. - Special Call

To discuss that the company entered into an agreement with the life sciences team at Google to jointly develop a series of next-generation CGM products

DexCom, Inc. Enters Agreement with Google to Jointly Develop Series of Next-Generation CGM Products

DexCom, Inc. announced that it has entered into an agreement with the life sciences team at Google to jointly develop a series of next-generation CGM products that are designed to be smaller and less expensive than existing technologies. These new products will incorporate Google’s miniaturized electronics platform with DexCom’s best-in-class sensor technology. This collaboration also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care. Initial products to be developed under the agreement will focus on minimizing both the cost and size of CGM body worn components. The products will be designed to be disposable, and will be intended for use across all diabetes markets. The goal is to empower more people to control their diabetes with real-time and actionable information by developing a low-cost, small, bandage-sized sensor that is connected to the cloud.

DexCom, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

DexCom, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $93.2 million compared to $58.8 million a year ago. Operating loss was $3.6 million compared to $5.8 million a year ago. Net loss was $3.7 million or $0.05 per basic and diluted share compared to $6.0 million or $0.09 per basic and diluted share a year ago. For the six months, the company reported total revenue of $166.0 million compared to $105.9 million a year ago. Operating loss was $16.3 million compared to $18.1 million a year ago. Net loss was $16.6 million or $0.21 per basic and diluted share compared to $18.5 million or $0.25 per basic and diluted share a year ago.

Tandem Diabetes Care Announces Development Agreement with Dexcom, Inc. for Integration of Future Generation Continuous Glucose Monitoring Systems

Tandem Diabetes Care, Inc. announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring (CGM) systems.

DexCom, Inc. to Report Q2, 2015 Results on Aug 05, 2015

DexCom, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $94.19 USD +0.45

DXCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.02 USD +0.38
Insulet Corp $29.71 USD +0.36
Merge Healthcare Inc $7.09 USD 0.00
Smiths Group PLC 1,129 GBp +27.00
Tandem Diabetes Care Inc $11.70 USD +0.66
View Industry Companies
 

Industry Analysis

DXCM

Industry Average

Valuation DXCM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.5x
Price/Book 44.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.